HK1118336A1 - Elisa assays using prion-specific peptide reagents - Google Patents

Elisa assays using prion-specific peptide reagents

Info

Publication number
HK1118336A1
HK1118336A1 HK08109773.6A HK08109773A HK1118336A1 HK 1118336 A1 HK1118336 A1 HK 1118336A1 HK 08109773 A HK08109773 A HK 08109773A HK 1118336 A1 HK1118336 A1 HK 1118336A1
Authority
HK
Hong Kong
Prior art keywords
prion
elisa assays
specific peptide
peptide reagents
reagents
Prior art date
Application number
HK08109773.6A
Other languages
English (en)
Inventor
David Peretz
Melissa Michelitsch
Celine Hu
Xuemei Wang
Man Gao
Michael Connolly
Thomas Horn
Ronald Zuckermann
David Chien
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Publication of HK1118336A1 publication Critical patent/HK1118336A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK08109773.6A 2005-01-13 2008-09-03 Elisa assays using prion-specific peptide reagents HK1118336A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64431405P 2005-01-13 2005-01-13
US65249305P 2005-02-11 2005-02-11
PCT/US2006/001437 WO2006076687A2 (en) 2005-01-13 2006-01-13 Elisa assays using prion-specific peptide reagents

Publications (1)

Publication Number Publication Date
HK1118336A1 true HK1118336A1 (en) 2009-02-06

Family

ID=36678266

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08109773.6A HK1118336A1 (en) 2005-01-13 2008-09-03 Elisa assays using prion-specific peptide reagents

Country Status (11)

Country Link
US (1) US20090130774A1 (xx)
EP (1) EP1848831A4 (xx)
JP (3) JP5162250B2 (xx)
CN (1) CN101166976B (xx)
AU (1) AU2006204705C1 (xx)
BR (1) BRPI0606529A2 (xx)
CA (1) CA2594840A1 (xx)
HK (1) HK1118336A1 (xx)
MX (1) MX2007008497A (xx)
NZ (2) NZ560535A (xx)
WO (1) WO2006076687A2 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
CA2621767A1 (en) 2005-09-09 2007-03-15 Novartis Ag Prion-specific peptoid reagents
EP2142934B1 (en) * 2007-04-04 2011-10-26 Novartis AG Prion assay
US20110189692A1 (en) * 2008-04-30 2011-08-04 Novartis Ag Assay for pathogenic conformers
WO2010003227A1 (en) * 2008-07-08 2010-01-14 Amorfix Life Sciences Ltd. Detection of protein aggregates
EP2496947A1 (en) * 2009-11-04 2012-09-12 Novartis AG Positively charged species as binding reagents in the separation of protein aggregates from monomers
GB201015569D0 (en) * 2010-09-16 2010-10-27 Medical Res Council Blood assay for prions
WO2012099576A1 (en) * 2011-01-18 2012-07-26 Baxter International Inc. Measurement of anti-amyloid antibodies in human blood
DE102011057019A1 (de) * 2011-12-23 2013-06-27 Forschungszentrum Jülich GmbH Standard zur Quantifizierung von pathogenen Aggregaten aus körpereigenen Proteinen
CN102879577B (zh) * 2012-11-01 2014-04-09 山东龙美生物医学科技有限公司 一种检测朊病毒的试剂盒及其制备方法
ES2958531T3 (es) 2015-10-14 2024-02-09 X Therma Inc Composiciones y métodos para reducir la formación de cristales de hielo

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US658619A (en) * 1900-02-02 1900-09-25 George L Clark Tire-supporting frame.
US4006117A (en) * 1973-01-24 1977-02-01 Hooker Chemicals & Plastics Corporation Amine phosphite antioxidants
US4244721A (en) * 1979-01-31 1981-01-13 Pedro Buarque De Macedo Method of making composite borosilicate glass articles
US4569526A (en) * 1980-07-02 1986-02-11 Gamma-Delta Games, Inc. Vectorial and Mancala-like games, apparatus and methods
US4666160A (en) * 1980-07-02 1987-05-19 Hamilton Clarence Q Apparatus for playing
US4507230A (en) * 1982-05-12 1985-03-26 Research Corporation Peptide synthesis reagents and method of use
US4952496A (en) * 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
DE3500180A1 (de) * 1985-01-04 1986-07-10 Ernst Prof. Dr. 7400 Tübingen Bayer Pfropfcopolymerisate aus vernetzten polymeren und polyoxyethylen, verfahren zu ihrer herstellung und ihre verwendung
US4695053A (en) * 1986-03-07 1987-09-22 Bally Manufacturing Corporation Gaming device having player selectable winning combinations
US5292814A (en) * 1987-04-29 1994-03-08 Ernst Bayer Process for the preparation of monodispersed polymer beads
DE69023900D1 (de) * 1989-02-24 1996-01-11 Univ California Gentechnologisch veränderte immunglobuline.
US5231167A (en) * 1989-09-08 1993-07-27 The Regents Of The University Of California Immunoglobulin-binding polypeptides
US5306812A (en) * 1989-09-08 1994-04-26 The Regents Of The University Of California Immunoglobulin-binding polypeptides
US5965695A (en) * 1990-05-15 1999-10-12 Chiron Corporation Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such
EP0592423B1 (en) * 1990-08-06 2000-11-15 Chiron Corporation Methods for the identification of cytokine convertase inhibitors
EP0620761A1 (en) * 1991-01-04 1994-10-26 Perseptive Biosystems, Inc. Sulfonamide bonded hydrophilic coatings
US5665539A (en) * 1991-07-12 1997-09-09 The Regents Of The University Of California Immuno-polymerase chain reaction system for antigen detection
JP4233604B2 (ja) * 1991-12-03 2009-03-04 プロセリックス メディスンズ ディベロップメント リミテッド プリオンタンパク質のフラグメント
US5424413A (en) * 1992-01-22 1995-06-13 Gen-Probe Incorporated Branched nucleic acid probes
US5877278A (en) * 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
US5652138A (en) * 1992-09-30 1997-07-29 The Scripps Research Institute Human neutralizing monoclonal antibodies to human immunodeficiency virus
US5524888A (en) * 1994-04-28 1996-06-11 Bally Gaming International, Inc. Gaming machine having electronic circuit for generating game results with non-uniform probabilities
US5565186A (en) * 1994-05-13 1996-10-15 The Regents Of The University Of California Method of detecting prions in a sample and transgenic animal used for same
US5908969A (en) * 1994-05-13 1999-06-01 The Regents Of The University Of California Method of detecting prions in a sample and transgenic animal used for same
US5792901A (en) * 1994-05-13 1998-08-11 The Regents Of The University Of California Detecting prions in a sample and prion preparation and transgenic animal used for same
US6376170B1 (en) * 1994-10-03 2002-04-23 The Scripps Research Institute Ligand capture-directed selection of antibody
US5639581A (en) * 1994-10-24 1997-06-17 Fuji Xerox Co., Ltd. Charge transporting polymer, process for producing the same, and organic electronic device containing the same
EP1416280A3 (en) * 1995-09-14 2005-08-10 The Regents of the University of California Antibodies specific for native PrPsc
US5750361A (en) * 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
US5985557A (en) * 1996-01-24 1999-11-16 Third Wave Technologies, Inc. Invasive cleavage of nucleic acids
US6090606A (en) * 1996-01-24 2000-07-18 Third Wave Technologies, Inc. Cleavage agents
US5713793A (en) * 1996-04-05 1998-02-03 Oris, L.L.C. Sporting event options market trading game
WO1997043649A1 (en) * 1996-05-14 1997-11-20 Winnacker Ernst Ludwig CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿
US5743525A (en) * 1996-07-01 1998-04-28 Haddad; George N. Sporting event wagering system
US6251433B1 (en) * 1996-08-13 2001-06-26 Chiron Corporation Polycationic polymers
BR9712289A (pt) * 1996-10-10 1999-08-31 Probe International Composições e métodos para o tratamento de infecções virais
EP1015013A4 (en) * 1997-01-10 2002-07-24 Massachusetts Inst Technology TREATMENT OF NEUROTOXICITY IN ALZHEIMER'S DISEASE BY BETA-AMYLOID PEPTIDES
US6617119B2 (en) * 1997-02-21 2003-09-09 The Regents Of The University Of California Assay for specific strains of multiple disease related conformations of a protein
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
US20010001061A1 (en) * 1997-02-21 2001-05-10 Prusiner Stanley B. Assay for disease related conformation of a protein
US5888136A (en) * 1997-03-13 1999-03-30 Herbert; Richard A. Wagering system and method of wagering
US6010404A (en) * 1997-04-03 2000-01-04 Walker Asset Management Limited Partnership Method and apparatus for using a player input code to affect a gambling outcome
US7160189B2 (en) * 1997-04-03 2007-01-09 Walker Jay S Systems and methods for determining an outcome of a game on a gaming device based on a factor other than a random number
US7005295B1 (en) * 1997-04-16 2006-02-28 Wyeth β-amyloid peptide-binding proteins and polynucleotides encoding the same
JP4727769B2 (ja) * 1997-04-28 2011-07-20 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 試薬再循環を用いてオリゴマー、特に、ペプトイドを合成するための装置
US6227972B1 (en) * 1997-07-01 2001-05-08 Walker Digital, Llc Method and apparatus for expiration of prepaid slot machine plays
JP4223681B2 (ja) * 1997-09-19 2009-02-12 エボテック・アーゲー 病原性タンパク質沈着の基礎構造の会合の測定方法
NZ504365A (en) * 1997-11-19 2003-02-28 Robert A A method, apparatus and system for lottery gaming
US6214565B1 (en) * 1998-10-09 2001-04-10 The Regents Of The University Of California Assay for disease related conformation of a protein and isolating same
WO1999042829A1 (en) * 1998-02-20 1999-08-26 The Regents Of The University Of California Assay for specific strains of multiple disease related conformations of a protein
ATE302269T1 (de) * 1998-04-14 2005-09-15 Sugen Inc Ste20-verwandte proteinkinasen
US6211149B1 (en) * 1998-08-03 2001-04-03 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors of formation of protease resistant prion protein
US6358150B1 (en) * 1998-10-29 2002-03-19 Racetech Llc Methods and apparatus for parimutuel historical gaming
GB2348203B (en) * 1998-11-04 2002-06-19 Imp College Innovations Ltd Solube beta-forms of prion proteins, methods of preparation and use
AU3474100A (en) * 1999-01-25 2000-08-07 Minerva Biotechnologies Corporation Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
US6551843B1 (en) * 1999-01-29 2003-04-22 Immunivest Corporation Methods for enhancing binding interactions between members of specific binding pairs
US6709330B1 (en) * 1999-08-20 2004-03-23 Ameritrade Holding Corporation Stock simulation engine for an options trading game
US6394899B1 (en) * 1999-10-29 2002-05-28 Stephen Tobin Walker Method of playing a knowledge based wagering game
FR2801106B1 (fr) * 1999-11-12 2007-10-05 Commissariat Energie Atomique Procede de diagnostic d'une esst provoquee par une souche d'atnc dans un echantillon biologique et son utilisation dans le diagnostic differentiel des differentes souches d'atnc
US6235483B1 (en) * 2000-01-31 2001-05-22 Agilent Technologies, Inc. Methods and kits for indirect labeling of nucleic acids
JP2003523348A (ja) * 2000-02-16 2003-08-05 ノースウェスタン ユニバーシティ ポリペプトイド肺サーファクタント
JP2004513409A (ja) * 2000-05-01 2004-04-30 シーエフピーエイチ，　エル．エル．シー． イベント結果についてのリアルタイムの双方向賭博
US6511809B2 (en) * 2000-06-13 2003-01-28 E. I. Du Pont De Nemours And Company Method for the detection of an analyte by means of a nucleic acid reporter
IL148202A0 (en) * 2000-06-20 2002-09-12 Caprion Pharmaceuticals Inc Copolymers and methods of treating prion-related diseases
US6505025B2 (en) * 2000-06-22 2003-01-07 Kyocera Corporation Color image forming apparatus and process
US6537548B1 (en) * 2000-07-27 2003-03-25 The Regents Of The University Of California Antibodies specific for ungulate PrP
US20030092613A1 (en) * 2000-08-14 2003-05-15 Lee Daniel H. S. Alpha7 nicotinic receptor peptides as ligands for beta amyloid peptides
US20020087447A1 (en) * 2000-09-19 2002-07-04 Gazebo Inc. System and method for managing and executing event based investments
US6721761B2 (en) * 2000-12-20 2004-04-13 American Management Systems, Inc. System for assigning digital identifiers to telephone numbers and IP numbers
WO2002057793A2 (en) * 2001-01-19 2002-07-25 Baxter International Inc. Method of detecting prp protein and kits therefor
US6527270B2 (en) * 2001-02-13 2003-03-04 Casino Advisory Services, Inc. Method of effecting multiple wagers on a sports or other event
US20020115488A1 (en) * 2001-02-22 2002-08-22 Nicholas Berry System and method for conducting an online competition
US7166471B2 (en) * 2001-05-31 2007-01-23 Arete Associates Misfolded protein sensor method in body fluids
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
US6869360B2 (en) * 2001-09-20 2005-03-22 Konami Gaming, Inc. Gaming apparatus and method including a multiplier feature and bonus features
EP1572894B1 (en) * 2001-11-21 2016-04-13 New York University Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha synuclein, or polyglutamine repeats for induction of an immune response thereto
US7040982B1 (en) * 2001-11-23 2006-05-09 Igt Financial trading game
US20040052928A1 (en) * 2002-09-06 2004-03-18 Ehud Gazit Peptides and methods using same for diagnosing and treating amyloid-associated diseases
EP1478931B2 (en) * 2002-02-28 2018-11-07 Microsens Biophage Limited Binding of pathological forms of prion proteins
EP1572937B1 (en) * 2002-04-09 2012-02-08 The Scripps Research Institute Motif-grafted hybrid polypeptides and uses thereof
US20050119962A1 (en) * 2002-07-03 2005-06-02 Bowen Christopher K. Method and system for securitizing contracts valued on an index
DE10230141B4 (de) * 2002-07-04 2004-07-15 Priontype Gmbh Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
EP1382971A1 (en) * 2002-07-17 2004-01-21 Pepscan Systems B.V. Detection of prion disease
US20040072236A1 (en) * 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
WO2004077368A2 (en) * 2003-02-21 2004-09-10 Walker, Digital, Llc Et Al. Method and apparatus for setting game parameters
US7962400B2 (en) * 2003-04-02 2011-06-14 Cfph, Llc System and method for wagering based on the movement of financial markets
ES2436638T3 (es) * 2003-04-04 2014-01-03 Pathogen Removal And Diagnostic Technologies, Inc. Materiales de unión de proteínas del prión y métodos de uso
WO2004092197A2 (en) * 2003-04-07 2004-10-28 The Regents Of The University Of California Amyloid-specific peptides and uses thereof
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
WO2005016127A2 (en) * 2003-08-13 2005-02-24 Chiron Corporation Prion-specific peptide reagents
US7311600B2 (en) * 2003-08-22 2007-12-25 Gameline, Llc Game based upon fluctuations of an objective environment
US7614948B2 (en) * 2003-09-15 2009-11-10 Igt Multi-player bingo with slept awards reverting to progressive jackpot pool
KR100505713B1 (ko) * 2003-10-22 2005-08-03 삼성전자주식회사 쉘로우 트렌치 소자 분리막 및 쉘로우 트렌치 소자분리막의 형성 방법
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
US7482172B2 (en) * 2005-09-19 2009-01-27 Ortho-Clinical Diagnostics, Inc. Peptides for discrimination of prions
US20060105839A1 (en) * 2004-11-15 2006-05-18 Delta Rangers, Inc. Casino game based on financial market activity
WO2006076497A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Osplation of pathogenic prions

Also Published As

Publication number Publication date
CN101166976A (zh) 2008-04-23
MX2007008497A (es) 2007-09-14
WO2006076687A2 (en) 2006-07-20
CA2594840A1 (en) 2006-07-20
US20090130774A1 (en) 2009-05-21
AU2006204705C1 (en) 2012-07-05
NZ560535A (en) 2011-01-28
BRPI0606529A2 (pt) 2009-06-30
CN101166976B (zh) 2013-06-12
JP2009115815A (ja) 2009-05-28
NZ587255A (en) 2012-03-30
JP5162250B2 (ja) 2013-03-13
EP1848831A2 (en) 2007-10-31
JP2008527382A (ja) 2008-07-24
WO2006076687A3 (en) 2007-12-13
AU2006204705A1 (en) 2006-07-20
JP2012181210A (ja) 2012-09-20
EP1848831A4 (en) 2008-11-05
AU2006204705B2 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
HK1118336A1 (en) Elisa assays using prion-specific peptide reagents
EP1858537A4 (en) PEPTIDE REAGENTS SPECIFIC TO PRION
HK1218126A1 (zh) 抗體
IL189542A0 (en) Proteolysis resistant antibody preparations
IL187106A (en) Sclerostin binds antibody
IL190472A0 (en) Anti-glypican-3 antibody
GB0503546D0 (en) Antibody
IL186425A0 (en) Stilbazium research assays
EP1772730A4 (en) REFUND TERM
HK1118558A1 (en) Reagents that bind ccx-ckr2
GB2432211B (en) Agglutination based assay system
GB0519605D0 (en) Assay
GB0511279D0 (en) Assay
EP1924938A4 (en) BIOCHEMICAL ASSAY METHODS
GB0408219D0 (en) High throughput assay
GB0503741D0 (en) Assay
GB0522008D0 (en) Screening assays
GB0518460D0 (en) Protein assay
GB0406914D0 (en) Assays
GB0425760D0 (en) Assays
GB0519895D0 (en) Assay
GB0507955D0 (en) Assay
GB0510562D0 (en) Assay
GB0514655D0 (en) Assay
GB0516870D0 (en) Assay

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180113